PF-00299804 in Stage IIIB or Stage IV Non-Small Cell Lung Cancer Not Responding to Standard Therapy for Advanced or Metastatic Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Michael Millward, MD
Sir Charles Gairdner Hospital - Nedlands
Study Chair - Penny Bradbury, MD
NCIC Clinical Trials Group
Study Chair - Peter Ellis, MD
Margaret and Charles Juravinski Cancer Centre
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
89 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Cer - Instituto Medico
Buenos Aires, B1878dvb Bs. As., Argentina
- Coiba Centro de Oncologia E Investigacion
Berazategui, Buenos Aires, Argentina
- Damic-Fundacion Rusculleda
Córdoba, Argentina
- Centro Medico San Roque
San Miguel de Tucumán, Argentina
- Royal Prince Alfred Hospital
Camperdown, New South Wales, Australia
- Concord Repatriation General Hospital
Concord, New South Wales, Australia
- St. George Hospital, Cancer Care Centre
Kogarah, New South Wales, Australia
- Prince of Wales Hospital
Randwick, New South Wales, Australia
- Royal North Shore Hospital
St Leonards, New South Wales, Australia
- Calvary Mater Newcastle Hospital
Waratah, New South Wales, Australia
- Westmead Hospital
Westmead, New South Wales, Australia
- the Prince Charles Hospital
Chermside, Queensland, Australia
- Nambour General Hospital
Nambour, Queensland, Australia
- Royal Adelaide Hospital
Adelaide, South Australia, Australia
- Monash Medical Centre
Clayton, Victoria, Australia
- Western Hospital
Footscray, Victoria, Australia
- Frankston Hospital - Peninsula Oncology Centre
Frankston, Victoria, Australia
- Geelong Hospital
Geelong, Victoria, Australia
- Austin Hospital
Heidelberg, Victoria, Australia
- Sir Charles Gairdner Hospital
Perth, Western Australia, Australia
- Centro de Oncologia E Radioterapia (cor) Mae de Deus
Porto Alegre, Rio Grande do Sul, Brazil
- Fundacao Pio Xii - Hospital de Cancer de Barretos
Barretos, São Paulo, Brazil
- Esho - Empresa de Servicos Hospitalares Ltda.
Brasilia, São Paulo, Brazil
- Centro de Pesquisa Clinica Do Hospital
Porto Alegre, São Paulo, Brazil
- Oxion Hospital Dia Oncologia Ltda - Oxion
Belo Horizonte, Brazil
- Facility name not stated
Centro, Brazil
- Nucleo de Oncologia Da Bahia
Salvador, Brazil
- Gram - Grupo de Assistencia Medica
São Paulo, Brazil
- Cross Cancer Institute
Edmonton, Alberta, Canada
- Bcca - Abbotsford Centre
Abbotsford British Columbia, British Columbia, Canada
- Bcca - Fraser Valley Cancer Centre
Surrey, British Columbia, Canada
- Bcca - Vancouver Cancer Centre
Vancouver, British Columbia, Canada
- Atlantic Health Sciences Corporation
Saint John, New Brunswick, Canada
- Dr. H. Bliss Murphy Cancer Centre
St. John's, Newfoundland and Labrador, Canada
- Qeii Health Sciences Centre
Halifax, Nova Scotia, Canada
- Health Sciences North
Greater Sudbury, Ontario, Canada
- Juravinski Cancer Centre at Hamilton Health Sciences
Hamilton, Ontario, Canada
- Cancer Centre of Southeastern Ontario at Kingston
Kingston, Ontario, Canada
- London Regional Cancer Program
London, Ontario, Canada
- Lakeridge Health Oshawa
Oshawa, Ontario, Canada
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 23 Dec 2009
- Primary completion
- 15 Jan 2014
- Completion
- 27 Nov 2015
- Last update posted
- 22 Aug 2023
- Registered enrollment
- 720
- Registry id
- NCT01000025
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.